| Literature DB >> 30692930 |
Arjan P Palstra1,2,3, Silvia Mendez1,3, Ron P Dirks4, Marcel J M Schaaf3.
Abstract
Forced sustained swimming exercise at optimal speed enhances growth in many fish species, particularly through hypertrophy of the white skeletal muscle. The exact mechanism of this effect has not been resolved yet. To explore the role of cortisol, we first subjected wild-type zebrafish to an exercise protocol validated for exercise-enhanced growth, and showed that exercised zebrafish, which indeed showed enhanced growth, had higher cortisol levels than the non-exercised controls. A central role was therefore hypothesized for the steroid hormone cortisol acting through the Glucocorticoid receptor (Gr). Second, we subjected wild-type zebrafish and zebrafish with a mutant Gr to exercise at optimal, suboptimal, and super-optimal speeds and compared them with non-exercised controls. Exercised zebrafish showed growth enhancement at all speeds, with highest growth at optimal speeds. In the Gr mutant fish, exercise resulted in growth enhancement similar to wild-type zebrafish, indicating that cortisol signaling through Gr cannot be considered as a main determinant of exercise-enhanced growth. Finally, the transcriptome of white skeletal muscle tissue was analyzed by RNA sequencing. The results of this analysis showed that in the muscle tissue of Gr mutant fish a lower number of genes is regulated by exercise than in wild-type fish (183 vs. 351). A cluster of 36 genes was regulated by exercise in both wild-type and mutant fish, and in this cluster genes involved in transcriptional regulation and protein ubiquitination were overrepresented. Because these two processes appear to be regulated in both wild type and mutant fish, which both display exercise-enhanced growth, we suggest that they play an important role in the growth of muscles upon exercise.Entities:
Keywords: RNAseq; cortisol; glucocorticoid receptor; hypothalamic-pituitary-interrrenal (HPI) axis; swimming exercise physiology
Year: 2019 PMID: 30692930 PMCID: PMC6339955 DOI: 10.3389/fphys.2018.01889
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Experimental set-ups. Experiment I was executed with wild-type (wt) zebrafish with a control group sampled at the start of the experiment, a non-exercised group and an exercised group which was subjected to forced sustained swimming at the optimal swimming speed (Uopt) of 0.4 m s-1 for a period of 4 weeks in a swim tunnel. Experiment II had a similar set-up but was executed with wild-type zebrafish and Gr mutants. Now there were three exercise groups swimming at the sub optimal (
FIGURE 2Experiment I: Exercise effects on size and cortisol levels. (A) Total length (TL), (B) body weight (BW), and (C) cortisol levels in wild-type fish at the start of the experiment and after 4 weeks without or with subjection to the daily exercise protocol (non-ex/ex). Differences in letters mark significant differences (P < 0.05).
FIGURE 3Experiment II: Exercise effects on size in wild-type and Gr mutant zebrafish. (A) Standard length (SL) and (B) body weight (BW) in wild-type zebrafish (green), and (C) SL and (D) BW of Gr mutant zebrafish (orange), at the start of the experiment (start), after 4 weeks without (non-ex) and with subjection to the daily exercise protocol swimming at the suboptimal (
FIGURE 4Enriched functional categories of differentially expressed genes (DEGs) specific for wild-type zebrafish, for Gr mutants and the DEGs that both groups had in common. Also shown is the functional annotation clustering of the commonly expressed genes.
Genes associated with muscle growth and structure which are differentially expressed in wild-type and/or Gr mutant zebrafish, exercised at Uopt in comparison with non-exercised zebrafish, as fold change.
| Fold change (exercised vs. non-exercised) | ||
|---|---|---|
| Description | Wild-type | Gr mutant |
| fibroblast growth factor 13a | 2.80 | n.s. |
| oxidative stress induced growth inhibitor 1 | 0.21 | 0.16 |
| growth arrest-specific 7a | 12.26 | n.s. |
| opioid growth factor receptor-like 1 | 9.28 | n.s. |
| insulin-like growth factor binding protein 1a | 3.04 | n.s. |
| growth hormone receptor b | 0.32 | n.s. |
| insulin-like growth factor binding protein 6a | n.s. | 40.26 |
| growth regulation by estrogen in breast cancer 1 | n.s. | 6.05 |
| myosin, heavy chain b | 2.56 | n.s. |
| myosin IIIA | 4.32 | n.s. |
| tropomyosin 1 (alpha) | 2.70 | n.s. |
| myoglobin | 3.25 | n.s. |
| collagen, type XI, alpha 2 | 4.33 | n.s. |
| collagen, type VIII, alpha 1b | 3.88 | n.s. |
| collagen, type XI, alpha 1b | 3.26 | n.s. |
| collagen, type I, alpha 1a | 3.24 | n.s. |
| collagen, type I, alpha 2 | 3.19 | n.s. |
| collagen, type I, alpha 1b | 2.73 | n.s. |
| procollagen, type V, alpha 1 | 2.57 | n.s. |
| collagen, type VI, alpha 1 | 2.52 | n.s. |
| collagen, type VI, alpha 2 | 2.45 | n.s. |
| collagen, type X, alpha 1b | n.s. | 10.61 |